Literature DB >> 9632660

An oligonucleotide inhibits oligomerization of a rolling circle initiator protein at the pT181 origin of replication.

A C Zhao1, R A Ansari, M C Schmidt, S A Khan.   

Abstract

A large number of plasmids have been shown to replicate by a rolling circle (RC) mechanism. The initiators encoded by these plasmids have origin-specific, nicking-closing activity that is required for the initiation and termination of RC replication. Since the initiators of many RC plasmids are rate-limiting for replication, these proteins are usually inactivated after supporting one round of replication. In the case of the pT181 plasmid, inactivation of the initiator RepC protein occurs by the attachment of an oligonucleotide to its active tyrosine residue. We have generated the inactivated form of RepC, termed RepC*, in vitro and investigated the effects of attachment of the oligonucleotide on its various biochemical activities. Our results demonstrate that while RepC* is inactive in nicking-closing and replication activities due to the blockage of its active tyrosine residue, it is competent in origin DNA binding and DNA religation activities. We have investigated the oligomeric state of RepC and RepC* and found that RepC exists as a dimer in solution and can oligomerize on the DNA. We have generated heterodimers in vitro between the wild-type and epitope-tagged RepC proteins. In electrophoretic mobility shift experiments, the initiator heterodimers generated a novel DNA-protein complex, demonstrating that it binds to DNA as a dimer. We have shown that a DNA binding mutant of RepC can be targeted to the origin in the presence of the wild-type protein primarily through a protein-protein interaction. Interestingly, RepC* is defective in its ability to oligomerize on the DNA. RepC* inhibited the DNA binding and replication activity of wild-type RepC to only a very limited extent, suggesting that it may play only a minor regulatory role in replication in vivo. Based on these and earlier results, we propose a model for the role of RepC during the initiation and termination of pT181 RC replication.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9632660     DOI: 10.1074/jbc.273.26.16082

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  5 in total

1.  Plasmid replication initiator RepB forms a hexamer reminiscent of ring helicases and has mobile nuclease domains.

Authors:  D Roeland Boer; José A Ruíz-Masó; José R López-Blanco; Alexander G Blanco; Mireia Vives-Llàcer; Pablo Chacón; Isabel Usón; F Xavier Gomis-Rüth; Manuel Espinosa; Oscar Llorca; Gloria del Solar; Miquel Coll
Journal:  EMBO J       Date:  2009-06-03       Impact factor: 11.598

2.  Genetic and biochemical characterization of the Streptococcus pneumoniae PcrA helicase and its role in plasmid rolling circle replication.

Authors:  J A Ruiz-Masó; S P Anand; M Espinosa; S A Khan; G del Solar
Journal:  J Bacteriol       Date:  2006-08-25       Impact factor: 3.490

3.  Dynamics of DNA nicking and unwinding by the RepC-PcrA complex.

Authors:  Carolina Carrasco; Cesar L Pastrana; Clara Aicart-Ramos; Sanford H Leuba; Saleem A Khan; Fernando Moreno-Herrero
Journal:  Nucleic Acids Res       Date:  2020-02-28       Impact factor: 16.971

4.  Conformational plasticity of RepB, the replication initiator protein of promiscuous streptococcal plasmid pMV158.

Authors:  D Roeland Boer; José Angel Ruiz-Masó; Manuel Rueda; Maxim V Petoukhov; Cristina Machón; Dmitri I Svergun; Modesto Orozco; Gloria del Solar; Miquel Coll
Journal:  Sci Rep       Date:  2016-02-15       Impact factor: 4.379

5.  Molecular dissection of the replication system of plasmid pIGRK encoding two in-frame Rep proteins with antagonistic functions.

Authors:  Paweł Wawrzyniak; Agnieszka Sobolewska-Ruta; Piotr Zaleski; Natalia Łukasiewicz; Paulina Kabaj; Piotr Kierył; Agata Gościk; Anna Bierczyńska-Krzysik; Piotr Baran; Anna Mazurkiewicz-Pisarek; Andrzej Płucienniczak; Dariusz Bartosik
Journal:  BMC Microbiol       Date:  2019-11-13       Impact factor: 3.605

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.